|
|
|
Insider
Information: |
Wentworth Kerry |
Relationship: |
Chief Regulatory Officer |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
57,410 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$25,461 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
57,410 |
|
|
Total
Value |
$25,461 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-91.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Agenus Inc |
AGEN |
VP, Clinical, Reg & Qual |
2014-02-26 |
57,410 |
|
0 |
Premium* |
|
Flexion Therapeutics Inc |
FLXN |
Chief Regulatory Officer |
2021-11-19 |
0 |
2021-11-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
|
2021-11-19 |
4 |
D |
$8.50 |
$51,000 |
I/I |
(6,000) |
0 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
|
2021-11-19 |
4 |
D |
$8.50 |
$1,197,166 |
D/D |
(140,843) |
0 |
0 |
- |
|
AGEN |
Agenus Inc |
VP, Reg Affairs & Clinical Ops |
|
2006-07-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,500 |
|
- |
|
AGEN |
Agenus Inc |
VP Reg Affairs & Clinical Ops |
|
2008-01-07 |
4 |
D |
$2.15 |
$5,551 |
D/D |
(2,582) |
5,885 |
0 |
- |
|
AGEN |
Agenus Inc |
VP Reg Affairs & Clinical Ops |
|
2008-03-24 |
4 |
D |
$2.28 |
$1,243 |
D/D |
(545) |
7,007 |
0 |
- |
|
AGEN |
Agenus Inc |
VP Reg Affairs & Clinical Ops |
|
2008-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,667 |
7,552 |
0 |
- |
|
AGEN |
Agenus Inc |
VP Reg Affairs & Clinical Ops |
|
2008-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
7,906 |
8,467 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
|
2019-01-03 |
4 |
AS |
$12.36 |
$7,688 |
D/D |
(622) |
11,207 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
|
2018-10-08 |
4 |
D |
$18.60 |
$18,637 |
D/D |
(1,002) |
11,476 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
|
2018-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,333 |
12,307 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
|
2018-06-20 |
4 |
A |
$21.22 |
$3,629 |
D/D |
171 |
12,478 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
|
2018-10-08 |
4/A |
D |
$18.60 |
$18,637 |
D/D |
(1,002) |
14,876 |
0 |
- |
|
AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
|
2011-12-29 |
4 |
S |
$2.01 |
$17,967 |
D/D |
(8,939) |
15,478 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
|
2018-10-06 |
4/A |
OE |
$0.00 |
$0 |
D/D |
3,400 |
15,878 |
0 |
- |
|
AGEN |
Agenus Inc |
VP, Clin., Reg. and Qual. |
|
2009-06-25 |
4 |
S |
$1.97 |
$49,250 |
D/D |
(25,000) |
21,172 |
0 |
- |
|
AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
|
2011-12-28 |
4 |
S |
$2.09 |
$3,956 |
D/D |
(1,893) |
24,417 |
0 |
- |
|
AGEN |
Agenus Inc |
VP Reg Aff and Clinical Ops |
|
2008-07-10 |
4 |
D |
$1.76 |
$11,181 |
D/D |
(6,353) |
24,672 |
0 |
- |
|
AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
|
2011-12-27 |
4 |
S |
$2.14 |
$6,754 |
D/D |
(3,156) |
26,309 |
0 |
- |
|
AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
|
2011-12-23 |
4 |
S |
$2.20 |
$1,947 |
D/D |
(886) |
29,465 |
0 |
- |
|
AGEN |
Agenus Inc |
VP Reg Aff and Clinical Ops |
|
2009-01-05 |
4 |
D |
$0.48 |
$1,239 |
D/D |
(2,582) |
29,997 |
0 |
- |
|
AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
|
2012-06-21 |
4 |
D |
$5.05 |
$74,659 |
D/D |
(14,784) |
30,283 |
0 |
- |
|
AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
|
2011-12-22 |
4 |
S |
$2.19 |
$3,759 |
D/D |
(1,716) |
30,351 |
0 |
- |
|
AGEN |
Agenus Inc |
VP, Clinical, Req & Quality |
|
2012-07-26 |
4 |
A |
$4.61 |
$3,199 |
D/D |
694 |
30,977 |
0 |
- |
|
AGEN |
Agenus Inc |
VP Reg Aff and Clinical Ops |
|
2008-07-10 |
4 |
A |
$0.00 |
$0 |
D/D |
24,018 |
31,025 |
0 |
- |
|
AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
|
2011-12-21 |
4 |
S |
$2.24 |
$7,641 |
D/D |
(3,414) |
32,067 |
0 |
- |
|
72 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|